scholarly journals A Phase 1, Randomized, Open‐Label, Safety, Tolerability, and Comparative Bioavailability Study of Intranasal Dihydroergotamine Powder (STS101), Intramuscular Dihydroergotamine Mesylate, and Intranasal DHE Mesylate Spray in Healthy Adult Subjects

2020 ◽  
Vol 60 (4) ◽  
pp. 701-712 ◽  
Author(s):  
Detlef Albrecht ◽  
Mic Iwashima ◽  
Debbie Dillon ◽  
Stuart Harris ◽  
Jeff Levy
Author(s):  
Jesús Cebrecos ◽  
James D. Carlson ◽  
Gregorio Encina ◽  
Mounia Lahjou ◽  
Artur Sans ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document